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Introduction
Many alkaloids containing a tetrahydro-b-carboline skeleton
have been isolated from natural sources. Several of them have
well-known pharmaceutical effects and are used in therapy. As
examples, reserpine displays antihypertensive activity,[1] while
vincristine and vinblastine exhibit cytotoxic activity.[2] In view
of their potential pharmaceutical activity, tetrahydro-b-carbo-
line alkaloids are currently at the forefront of research. New al-
kaloids have recently been isolated from Vinca major, including
vincamajorines A and B[3] and vinmajines A–I.[4] Terpenoid
indole alkaloids, mappiodines A–C, and mappiodosides A–G
are found in the stems of Mappianthus iodoides.[5] Harmicine,
extracted in optically pure form from Kopsia griffithii, has anti-
leishmanial[6] and antinociceptive effects.[7] The antiproliferative
activity of arborescidine alkaloids and their derivatives has
been evaluated in vitro in human tumor cell lines.[8] A number
of studies have reported antimalarial effects of tetrahydro-b-
carbolines such as (+)-7-bromotrypargine, which was extracted
from an Australian marine sponge,[9] and some pyridoxal b-car-
bolines derivatives.[10] Trujillo and co-workers investigated tet-
rahydro-b-carboline-1-carboxylic acids and their analogs, such
as ()-5, as inhibitors of mitogen-activated protein kinase-
activated protein kinase 2.[11] Syntheses of b-carboline alkaloids,
such as henrycinol A and B[12] or Eg5, an inhibitor of hydantoin
hybrids, have also been reported.[13] Several routes for the syn-
thesis of pharmacologically important natural products have
been reviewed.[14,15]
Continuous-flow techniques are increasingly more often
used in lipase-catalyzed transformations, for example acylation
reactions[16–18] or esterifications, such as the resolution of flurbi-
profen[19] and sugar ester synthesis.[20] Most of the lipase-cata-
lyzed reactions involving the use of continuous-flow tech-
niques have been reviewed, for example, the compilation by
Itabaiana and co-workers.[21]
On the basis of earlier excellent results on the enzymatic
preparation of various N-Boc-protected tetrahydroisoquino-
lines, intermediates for the preparation of crispine A,[22] homo-
calycotomine,[23] or calycotomine,[24] we set out to develop
a new enzymatic method for the resolution of new tetrahydro-
b-carboline derivatives: 1-hydroxymethyl-1,2,3,4-tetrahydro-b-
carboline [()-4] , 1-hydroxymethyl-6-methoxy-1,2,3,4-tetrahy-
dro-b-carboline [()-5] , and 1-hydroxymethyl-6-fluoro-1,2,3,4-
tetrahydro-b-carboline [()-6] . We planned to carry out the
enantioselective O-acylation of Boc-protected derivatives of
the above-mentioned compounds [()-7, ()-8, and ()-9] .
Results and Discussion
The starting compounds [()-7, ()-8, and ()-9] were synthe-
tized through Pictet–Spengler cyclization of the corresponding
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tryptamine hydrochloride derivatives [1, 2, and 3] and glycolal-
dehyde, by a method from the literature.[25] Finally, to ensure
the acylation exclusively at the OH function, the nitrogen at
position 2 was Boc protected (Scheme 1).
A number of preliminary experiments were performed in
order to determine the optimal conditions for the enzymatic
acylation of ()-7 (Scheme 2). These preliminary reactions were
carried out in a continuous-flow system, using an H-Cube,[24]
considering the advantages ensured by this system vs. batch
reactions, such as facile automation, reproducibility, constant
reaction parameters, and rapid implementation of the reac-
tions (Figure 1).[26] The substrate and the acyl donor were dis-
solved in the solvent, and the solution was pumped through
a 70 mm-long heat- and pressure-resistant CatCart filled with
enzyme. We investigated how the enzyme, the acyl donor, the
solvent, temperature, and pressure influenced the enantiose-
lectivity and the reaction rate.
In an earlier study on the synthesis of N-Boc-protected caly-
cotomine enantiomers, the CAL-B (Candida antarctica lipase B)-
catalyzed enantioselective acylation (E>200) was performed
with vinyl acetate in toluene, with a flow rate of 0.1 mLmin¢1
in a continuous-flow system.[24] We therefore started the acyla-
tion of model compound ()-7 under similar conditions
(Table 1, entry 1). Poppe and co-workers[16] described the prep-
arative-scale resolution of different racemic secondary alcohols
by using a continuous-flow system and also at a flow rate of
0.1 mLmin¢1. CAL-B catalyzed the reaction with excellent enan-
tioselectivity (E>200), but the conversion (conv.=4%) was
very low after one cycle. Next, several other enzymes, such as
PS-IM (Burkholderia cepacia lipase), CAL-A (Candida antarctica
lipase A) and AK (Pseudomonas fruorescens lipase), were tested
under the same conditions (entries 2–4). Lipase PS-IM catalyzed
the reaction with excellent E (entry 2), but with an even lower
reaction rate than for CAL-B (entry 1). CAL-A displayed moder-
ate reactivity and low E (entry 4), while lipase AK practically did
not catalyze the reaction (no product was detected after one
cycle) (entry 3). In view of these results, CAL-B was chosen for
further optimization.
In an attempt to increase the reaction rate, the enzymatic
acylation of ()-7 was performed with other acyl donors
(Table 2). Ethyl acetate and isopropenyl acetate did not react
(entries 1 and 2). Although it is known that acylation with an
anhydride acyl donor may lead to ‘chemical esterification’ be-
sides enzymatic acylation, thereby causing a decrease in the
product enantiomeric excess,[27] two anhydride acyl donors, bu-
tyric anhydride (entry 4) and acetic anhydride,[28,29] (entry 5),
were also tested. When butyric anhydride was used, a low E
and a relatively good conversion were observed (entry 4).
Scheme 1. Synthesis of starting compounds ()-7, ()-8, and ()-9. Reagents and conditions : a) 1) water, HCl, glycolaldehyde dimer, 0 8C then 90 8C, 4 h,
2) NaOH, 87% [()-4] , 51% [()-5] , 91% [()-6] ; b) 1,4 dioxane, water, NaOH, (Boc)2O, 0 8C for 1 h then rt for 24 h, 81% [()-7] , 87% [()-8] , 73% [()-9] .
Scheme 2. Enzymatic resolution of ()-7, ()-8, and ()-9. Reagents and conditions : a) lipase CAL-B, acetic anhydride, toluene, 60 8C, 1.5 h: 47% [(R)-7] , 46%
[(S)-10] , 2.5 h: 47% [(R)-8] , 43% [(S)-11] , 2 h: 47% [(R)-9] , 45% [(S)-12] .
Figure 1. Enzyme-catalyzed resolution of ()-7 in a continuous-flow system.
Table 1. Enzyme screening for the acylation of ()-7[a] .
Entry Enzyme ees
[b] [%] eep
[b] [%] Conv. [%] E
1 CAL-B 4 99 4 >200
2 PS-IM 1.5 99 1.5 >200
3 AK No reaction
4 CAL-A 3 24 11 1.6
[a] Substrate (0.0125 mmol, 3.7 mg); CAL-B (230 mg), PS-IM (248 mg), AK
(338 mg), CAL-A (231 mg, 70 mm cartridge); toluene (1 mL); 1.1 equiv
vinyl acetate (1.2 mL); 45 8C; 0.1 mLmin¢1 flow rate; 1 bar; 1 cycle.
[b] According to HPLC.
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Under the same reaction conditions, acylation with acetic an-
hydride proceeded in a relatively fast reaction (conversion=
17%) with excellent enantioselectivity (E>200). Consequently,
acetic anhydride was chosen as acyl donor in further reactions.
We next investigated the acylation of ()-7 at different tem-
peratures (Table 3). When the temperature was increased from
60 8C (entry 1) to 70 8C (entry 2) and then to 80 8C (entry 3), the
reaction rate increased, but at the same time, E decreased.
In an effort to increase the reaction rate without a loss in
enantioselectivity, a set of experiments were performed in dif-
ferent solvents, such as toluene, methyl tert-butyl ether, aceto-
nitrile, diisopropyl ether, chloroform, and 1,4-dioxane (Table 4).
The results demonstrated excellent E (>200) in methyl tert-
butyl ether and 1,4-dioxane (entries 2 and 6), but the conver-
sions were very low (conv.4%). Excellent E (>200) and rela-
tively good reaction rates were observed in toluene and diiso-
propyl ether (entries 1 and 4). Finally, diisopropyl ether was
chosen for further reactions.
The pressure of the reactions performed in the continuous-
flow system was also examined (Table 5). It was interesting to
observe that at about 60 bar, the reaction rate reached a maxi-
mum (conversion=32% after one cycle, entry 4), and further
increase of the pressure resulted in a decrease in the conver-
sion.
The CAL-B-catalyzed acylation of ()-7 was next carried out
in an incubator shaker, under the optimized reaction condi-
tions for the H-Cube (CAL-B, diisopropyl ether, acetic anhy-
dride, 60 8C). The reaction performed in batch mode reached
a conversion of 46% after 3 h, but the enantioselectivity was
relatively low (E=36). Consecutively, the diisopropyl ether was
replaced by toluene, which also ensured good results when
the acylation of ()-7 was carried out in the H-Cube (Table 4,
entry 1 vs. 4). The batch reaction in toluene gave excellent
enantioselectivity (E>200) and a conversion of 48% after 3 h.
When the amount of acetic anhydride was increased from
1.1 equiv to 2 equiv, a higher reaction rate was observed (E>
200, conversion=50% after 3 h).
In the small-scale acylations of ()-8 and ()-9 under the
conditions optimized for ()-7 (CAL-B, 2 equiv acetic anhy-
dride, toluene, 60 8C), lower reaction rates and enantioselectivi-
ties were observed (Table 6). The results revealed that the en-
zymatic acylations slowed down or even stopped after a while,
and eep decreased considerably, as a consequence of chemical
Table 2. Acyl donor screening for the acylation of ()-7[a] .
Entry Acyl donor ees
[b] [%] eep
[b] [%] Conv. [%] E
1 ethyl acetate No reaction
2 isopropenyl
acetate
No reaction
3 vinyl acetate 4 99 4 >200
4 butyric
anhydride
31 63 32 6
5 acetic anhydride 20 99 17 >200
6 2,2,2-trifluoroethyl
butyrate
12 42 22 2.7
[a] Substrate (0.0125 mmol, 3.7 mg); CAL-B (230 mg, 70 mm cartridge) ;
toluene (1 mL); 1.1 equiv acyl donor; 60 8C, 0.1 mLmin¢1 flow rate; 1 bar;
1 cycle. [b]According to HPLC.
Table 3. Effects of temperature on E and the conversion in the acylation
of ()-7[a] .
Entry Temperature [8C] ees
[b] [%] eep
[b] [%] Conv. [%] E
1 60 20 99 17 >200
2 70 23 98 19 124
3 80 35 97 26 92
[a] Substrate (0.0125 mmol, 3.7 mg); CAL-B (230 mg, 70 mm cartridge) ;
toluene (1 mL); 1.1 equiv acetic anhydride (1.2 mL); 0.1 mLmin¢1 flow
rate; 1 bar; 1 cycle. [b] According to HPLC.
Table 4. Solvent screening for the acylation of ()-7[a] .
Entry Solvent ees
[b] [%] eep
[b] [%] Conv. [%] E
1 toluene 20 99 17 >200
2 methyl tert-butyl ether 4 99 4 >200
3 acetonitrile 1 95 1 39
4 diisopropyl ether 20 99 17 >200
5 chloroform 2 73 3 7
6 1,4-dioxane 3 99 3 >200
[a] Substrate (0.0125 mmol, 3.7 mg); CAL-B (230 mg, 70 mm cartridge) ;
solvent (1 mL); 1.1 equiv acetic anhydride (1.2 mL) ; 60 8C; 0.1 mLmin¢1
flow rate; 1 bar; 1 cycle. [b] According to HPLC.
Table 5. Effects of pressure on E and the conversion in the acylation of
()-7[a] .
Entry Pressure [bar] ees
[b] [%] eep
[b] [%] Conv. [%] E
1 1 18 99 15 >200
2 20 34 99 25 >200
3 40 35 99 26 >200
4 60 48 99 32 >200
5 80 34 99 25 >200
6 100 21 99 18 >200
[a] Substrate (0.0125 mmol, 3.7 mg); CAL-B (230 mg, 70 mm cartridge) ;
diisopropyl ether (1 mL); 1.1 equiv acetic anhydride (1.2 mL); 60 8C;
0.1 mLmin¢1 flow rate; 1 cycle. [b]According to HPLC.
Table 6. CAL-B-catalyzed O-acylation of ()-8 and ()-9 with acetic anhy-
dride.[a]
Entry Substrate Acetic anhydride
[equiv]
Time
[h]
ees
[b]
[%]
eep
[b]
[%]
Conv.
[%]
E
1 ()-8 2 3 69 99 41 >200
2 ()-8 2 7 70 95 42 82
3 ()-8 8 2.5 98 98 50 >200
4 ()-9 2 3 68 97 41 134
5 ()-9 2 7 75 89 45 39
6 ()-9 6 2 97 96 50 >200
[a] Substrate (0.0125 mmol) ; CAL-B (30 mg); toluene (1 mL); 60 8C. [b] Ac-
cording to HPLC.
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esterifications (entries 2 and 5). When the amount of acetic an-
hydride was increased from 2 equiv to 6 and then 8 equiv, the
reactions became faster, and when 50% conversions were ach-
ieved, the enantioselectivities were excellent (>200) (entries 3
and 6).
On the basis of the above results, the preparative-scale enzy-
matic resolutions of ()-7–()-9 were performed in toluene,
with CAL-B, acetic anhydride [2 equiv for ()-7, 8 equiv for ()-
8, 6 equiv for ()-9] , at 60 8C. The results are presented in
Table 7 and the Experimental Section.
Further transformations
The O-acylated enantiomers [(S)-10–(S)-12] were transformed
via methanolysis into the corresponding amino alcohols [(S)-7–
(S)-9] in K2CO3/MeOH at 60 8C without a loss in ee values (98%)
(Scheme 3). When the protecting Boc in (R)-8 and (S)-11 was
removed with 18% HCl at 80 8C, a considerable decrease in ee
(89%) was observed. Since methods of Boc deprotection, in-
cluding catalyst-free water-mediated,[30] and microwave (MW)-
assisted methods[31] are known in the literature, we performed
MW-assisted Boc group removal for (R)-7–(R)-9 and (S)-10–(S)-
12, in water at 100 8C.[32] This strategy resulted in the desired
products [(R)-4–(R)-6 and (S)-4–(S)-6] with high ee (96%).
For determination of the absolute configuration, amino alco-
hol 4 was transformed to its N-acetyl analog (13) by a known
literature method (Scheme 3).[33]
Determination of absolute configuration
The specific rotation earlier reported for (R)-13 (ee=98%) was
[a]D
25= +17.3 (c=0.2 in EtOH),[34] whereas the enantiomeric
13 that we prepared (see Experimental Section) gave [a]D
25=
+164 (c=0.2 in EtOH), with the same sign, but with a higher
order of magnitude, although the 1H NMR spectroscopic data
for our (R)-13 were similar to those given in the literature.[34][35]
Taking into account our earlier observations with regard to the
enantioselectivity in the CAL-B-catalyzed O-acylation of related
amino alcohols,[24] (S) selectivity was accepted in the CAL-B-cat-
alyzed O-acylation of ()-7.
Conclusion
An effective enzymatic method was developed for the enantio-
selective O-acylation of the primary hydroxyl group of tetrahy-
dro-b-carbolines ()-7, ()-8, and ()-9. Taking advantage of
the continuous-flow system, we carried out the preliminary ex-
periments in a continuous-flow system, while the preparative-
scale resolutions were performed as batch reactions (incubator
shaker). Excellent E values (>200) were observed when CAL-B
and acetic anhydride were used in toluene at 60 8C. Enantio-
meric N-Boc-protected amino alcohols [(R)-7–(R)-9] , and amino
esters [(S)-10–(S)-12] were obtained with high ee (96%) in
good yields (43%). The transformations of (R)-7–(R)-9 and
(S)-10–(S)-12 with MW-assisted Boc deprotection resulted in
the desired tetrahydro-b-carboline amino alcohols without
a drop in the ee values (96%).
Experimental Section
Materials and methods
CAL-B (lipase B from Candida antarctica, Catalog No. L4777, specifi-
cation:5000 Ug¢1) was purchased from Sigma–Aldrich; lipase AK
(Pseudomonas fruorescens) was from Amano Pharmaceuticals.
Lipase PS-IM (Burkholderia cepacia immobilized on diatomaceous
earth) was from Amano Enzyme Europe Ltd. Chyrazyme L-5 (lipase
A from Candida antarctica) was from Novo Nordisk. Reactions in
the continuous-flow system were carried out in the H-Cube from
Table 7. CAL-B-catalyzed preparative-scale resolution of ()-7–()-9[a] .
Alcohol recovered Ester produced
[(R)-7–(R)-9] [(S)-10–(S)-12]
Entry Substrate Time
[h]
Conv.
[%]
Yield
[%]
ee[b]
[%]
[a]D
25 Yield
[%]
ee[b]
[%]
[a]D
25
1 ()-7 1.5 50 47 98 +107.5[c] 46 98 ¢102.2[d]
2 ()-8 2.5 50 47 98 +82[e] 43 98 ¢92.3[f]
3 ()-9 2 49 47 96 +97[g] 45 98 ¢131.8[h]
[a] Toluene, with acetic anhydride, at 60 8C. [b] According to HPLC. [c] c=
0.34 in EtOH. [d] c=0.32 in EtOH. [e] c=0.23 in EtOH. [f] c=0.61 in EtOH.
[g] c=0.21 in EtOH. [h] c=0.38 in EtOH.
Scheme 3. Further transformations. Reagents and conditions : a) MeOH, K2CO3, 60 8C, 10 min, 90% [(S)-7] , 88% [(S)-8] , 75% [(S)-9] ; b) MW, water, 100 8C, 1 h,
52% [(S)-4] , 38% [(S)-5] , 28% [(S)-6] , 79% [(R)-4] , 38% [(R)-5] , 52% [(R)-6] ; c) CH2Cl2, water, acetic anhydride, NaOH, rt, 48 h, 49%.
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ThalesNano Inc (Budapest, Hungary). The stainless-steel cartridges
used (70 mm in length, 4 mm in internal diameter and 0.75 mL in
volume), were also from ThalesNano Inc. With CAL-B (230 mg) as
enzyme charge and a flow rate of 0.1 mLmin¢1 (toluene), the ex-
perimentally determined (staining procedure) residence time
within the packed bed of the reactor was 7 min and 40 s. The H-
cube was used in “no H2” mode. The
1H NMR and 13C NMR spectra
were recorded with a Bruker Avance DRX 400 instrument (Billerica,
MA, USA). Elemental analyses were performed with a PerkinElmer
CHNS-2400 Ser II Elemental Analyzer (Waltham, MA, USA). Optical
rotations were measured with a PerkinElmer 341 polarimeter. Mi-
crowave (MW) reactions were performed in a CEM Discover MW re-
actor (Matthews, NC, USA). Melting points were determined on
a Kofler apparatus.
The ee values of the N-Boc-protected amino alcohols [(R)-7–(R)-9)
and (S)-7–(S)-9] and amino esters [(S)-10–(S)-12)] were determined
directly, while those of the deprotected enantiomers [(R)-4–(R)-6
and (S)-4–(S)-6] were determined after derivatization with Boc2O by
using high-performance liquid chromatography (HPLC) with a Chir-
alpak OD-H column (4.6 mmÕ250 mm), eluent: n-hexane:isopropyl
alcohol (93:7), flow rate: 0.5 mLmin¢1, detection at 260 nm, at rt.
Retention times (min): for (R)-7: 27.7, (S)-7: 16.6, (R)-8 : 38.6, (S)-8 :
21.9, (R)-9 : 28.8, (S)-9 : 15.6, (S)-10 : 13.8, (R)-10 : 18.8, (S)-11: 17.0,
(R)-11: 25.3, (S)-12 : 12.6, and (R)-12 : 19.9. The ee value of N-acetyl
amino alcohol (R)-13 was determined with a Chiralpak IA column
(4.6 mmÕ250 mm), eluent: n-hexane:isopropyl alcohol (95:5), flow
rate: 0.5 mLmin¢1, detection at 210 nm, at rt. Retention times
(min): for (R)-13 : 92.8 and (S)-13 : 88.2.
Small-scale enzymatic resolutions
Small-scale experiments in the continuous-flow system: the race-
mic substrate [()-7, 0.0125 mmol] and the acyl donor (1.1 equiv)
were dissolved in the solvent (1 mL), and the mixtures were
pumped with an HPLC pump through the heated (45 8C, 60 8C,
70 8C, and 80 8C) and compressed (1 bar, 20 bar, 40 bar, 60 bar,
80 bar, and 100 bar) cartridge filled with enzyme (flow rate:
0.1 mLmin¢1).
Small-scale experiments in batch mode: the racemic compound
[()-7, ()-8, or ()-9, 0.0125 mmol] was dissolved in the solvent
(1 mL), and the enzyme (30 mgmL¢1) and acyl donor (2, 6, or
8 equiv of acetic anhydride) were then added. The mixture was
shaken at 60 8C.
Syntheses
Synthesis of racemic N-Boc-protected 1-hydroxymethyl-
1,2,3,4-tetrahydro-b-carboline [()-7]
Tryptamine hydrochloride (1, 5.9 g, 0.03 mol) was dissolved in
a mixture of water and 2 n HCl (15 mL). The solution was cooled
to 0 8C, and a solution of glycolaldehyde dimer (2.3 g, 0.02 mol, dis-
solved in 5 mL water) was added. The reaction mixture was stirred
at 90 8C for 4 h. The cooled solution was treated with activated
carbon, and then extracted with diethyl ether. To the aqueous
layer, 20% NaOH was added until pH 10, and the mixture was then
extracted with EtOAc (3Õ30 mL). The organic layer was dried on
anhydrous Na2SO4 and evaporated. The product ()-4 was purified
by column chromatography (5.2 g, yield: 87%, m.p.=146-147 8C,
light-yellow crystals, Rf=0.27, eluent: MeOH). Alcohol ()-4 (3.0 g,
0.015 mol) was dissolved in 80 mL 1,4-dioxane and cooled to 0 8C,
and a solution of NaOH (0.62 g, 0.016 mol, in 5 mL water) and then
a solution of di-tert-butyl dicarbonate (3.56 g, 0.016 mol, in 10 mL
1,4-dioxane) were added. The reaction was carried out at 1 h under
ice-cooling, and then at room temperature for 24 h. The reaction
mixture was extracted with dichloromethane (3Õ30 mL) and the
extract was dried on anhydrous Na2SO4 and evaporated. The result-
ing N-Boc-protected amino alcohol ( )-7 (3.6 g, yield: 81%, m.p.=
115-117 8C, light-yellow crystals from with diethyl ether.) was puri-
fied by column chromatography [Rf=0.23, eluent: n-hexane:EtOAc
(2:1)] .
1H NMR (400 MHz, CDCl3) for ()-4 : d=8.12–8.26 (br s, 1H, NH),
7.49–7.56 (d, J=7.69 Hz, 1H, Ar–H), 7.32–7.39 (d, J=8.14 Hz, 1H,
Ar–H), 7.10–7.23 (m, 2H, Ar–H), 4.18–4.26 (t, J=2.30 Hz, 1H, CH),
3.77–3.96 (m, 2H, CH2), 3.11–3.36 (m, 2H, CH2), 2.71–2.87 ppm (m,
2H, CH2) ;
13C NMR (400 MHz, [D4]MeOH) for ()-4 : d=135.35,
131.43, 125.98, 119.67, 117.22, 116.13, 109.46, 107.18, 62.11, 53.19,
40.17, 20.35 ppm; Anal. calcd. for C12H14N2O: C 71.26, H 6.98, N
13.85, found: C 71.21, H 6.93, N 13.79.
1H NMR (400 MHz, DMSO) for ()-7: d=10.66–10.87 (br s, 1H, NH),
7.35–7.43 (d, J=7.6 Hz, 1H, Ar–H), 7.28–7.35 (d, J=8.0 Hz, 1H, Ar–
H), 7.01–7.09 (t, J=7.3 Hz, 1H, Ar–H), 6.91–6.99 (t, J=7.2 Hz, 1H,
Ar–H),), 4.88–5.24 (m, 2H, CH2), 4.10–4.43 (m, 1H, CH), 3.69–3.84
(m, 2H, CH2), 2.57–2.74 (m, 2H, CH2), 1.44 ppm (s, 9H, C(CH3)3) ;
13C NMR (400 MHz, CDCl3) for ()-7: d=136.68, 132.30, 127.01,
122.24, 119.76, 118.50, 111.56, 81.10, 64.62, 53.32, 28.94, 21.91 ppm;
Anal. calcd. for C17H22N2O3 : C 67.53, H 7.33, N 9.26, found: C 67.43,
H 7.39, N 9.22.
Synthesis of racemic N-Boc-protected 1-hydroxymethyl-6
methoxy-1,2,3,4-tetrahydro-b-carboline [()-8]
With the procedure described above [5-methoxytryptamine hydro-
chloride (2, 1.0 g, 4.4 mmol), water (40 mL), 2 n HCl (2.8 mL), glyco-
laldehyde dimer (0.52 g, 4.3 mmol)] , the reaction resulted in ()-5
[0.52 g, yield: 51%, m.p.=152–153 8C, Rf=0.25, eluent: MeOH] as
yellow crystals. To a solution of ()-5 (0.52 g, 2.26 mmol) in 1,4-di-
oxane (35 mL), NaOH (0.09 g, 2.25 mmol) in water (5 mL) and di-
tert-butyl dicarbonate (0.54 g, 2.47 mmol) in 1,4-dioxane (5 mL)
were added. The method was as described above. ( )-8 [0.65 g,
yield: 87%, m.p.=155–156 8C from n-hexane, Rf=0.34, eluent: n-
hexane:EtOAc (2:1)] was obtained as light-yellow crystals.
1H NMR (400 MHz, CDCl3) for ()-5 : d=8.08–8.24 (br s, 1H, NH),
7.22–7.24 (d, 1H, J=8.80 Hz, Ar–H), 6.95 (s, 1H, Ar–H), 6.78–6.88 (d,
J=8 Hz, 1H, Ar–H), 4.13–4.26 (m, 1H, CH), 3.75–3.97 (m, 2H, CH2
overlapping with s, 3H, CH3), 3.04–3.37 (m, 2H, CH2), 2.63–
2.88 ppm (m, 2H, CH2) ;
13C NMR (400 MHz, [D4]MeOH) for ()-5 :
d=152.55, 132.38, 130.56, 126.30, 110.07, 109.48, 107.05, 98.70,
62.12, 53.90, 53.27, 40.23, 20.42 ppm; Anal. calcd. for C13H16N2O2 : C
67.22, H 6.94, N 12.06, found: C 67.20, H 6.88, N 12.14.
1H NMR (400 MHz, DMSO) for ()-8 : d=10.49-10.72 (br s, 1H, NH),
7.16–7.31 (d, 1H, J=8.48 Hz, Ar–H), 6.88 (s, 1H, Ar-H), 6.61–6.77
(dd, J=2.2 Hz, 8.7 Hz, 1H, Ar–H), 4.90–5.23 (m, 2H, CH2), 4.08–4.43
(m, 1H, CH), 3.70–3.85 (m, 2H, CH2 overlapping with s, 3H, CH3),
2.51–2.61 (m, 2H, CH2), 1.44 ppm (s, 9H, C(CH3)3) ;
13C NMR
(400 MHz, CDCl3) for ()-8 : d=154.45, 133.12, 131.80, 127.37,
112.18, 100.91, 81.05, 64.68, 56.42, 53.32, 28.90, 21.92 ppm; Anal.
calcd. for C18H24N2O4 : C 65.04, H 7.28, N 8.43, found: C 65.07, H
7.19, N 8.49.
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Synthesis of racemic N-Boc-protected 1-hydroxymethyl-6-
fluoro-1,2,3,4-tetrahydro-b-carboline, ()-9
With the procedure described above [5-fluorotryptamine hydro-
chloride (3, 1.0 g, 4.6 mmol), water (40 mL), 2 n HCl (2.5 mL), glyco-
laldehyde dimer (0.55 g, 4.6 mmol)] , the reaction resulted in ()-6
[0.93 g, yield: 91%, m.p.=138–141 8C, Rf=0.15, eluent: toluene:-
MeOH (1:1)] as yellow crystals. To a solution of ()-6 (0.83 g,
3.77 mmol) in 1,4-dioxane (30 mL), NaOH (0.15 g, 3.75 mmol) in
water (5 mL) and di-tert-butyl dicarbonate (0.91 g, 4.17 mmol) in
1,4-dioxane (5 mL) were added. The method was as described
above. The product ( )-9 [0.88 g, yield: 73%, m.p.=124–125 8C
from n-hexane, Rf=0.26, eluent: n-hexane:EtOAc (2:1)] was ob-
tained as light-yellow crystals.
1H NMR (400 MHz, [D4]MeOH) for ()-6 : d=7.16–7.28 (q, J=
4.44 Hz, 1H, Ar–H), 7.00–7.08 (dd, J=2.48 Hz, 9.68 Hz, 1H, Ar–H),
6.72–6.85 (dt, J=2.44 Hz, 9.16 Hz, 1H, Ar–H), 4.03–4.15 (m, 1H,
CH), 3.78–3.92 (m, 1H, CH2), 3.56–3.66 (m, 1H, CH2), 3.25–3.32 (m,
1H, CH2), 2.93–3.03 (m, 1H, CH2), 2.62–2.78 ppm (m, 2H, CH2) ;
13C NMR: (400 MHz, [D4]MeOH) for ()-6 : d=157.62, 155.31,
133.72, 131.84, 126.26, 110.07, 107.34, 100.86, 62.02, 47.39, 40.16,
20.28 ppm; Anal. calcd. for C12H13FN2O: C 65.44, H 5.95, N 12.72,
found: C 65.27, H 5.99, N 12.85.
1H NMR (400 MHz, DMSO) for ()-9 : d=10.78–10.92 (br s, 1H, NH),
7.25–7.34 (q, J=8.7 Hz, 1H, Ar–H), 7.09–7.18 (dd, J=2.4 Hz, 9.8 Hz,
1H, Ar–H), 6.83–6.91 (dt, J=2.8 Hz, 9.4 Hz, 1H, Ar–H), 4.95–5.19 (m,
2H, CH2), 4.11–4.39 (m, 1H, CH), 3.69–3.81 (m, 2H, CH2), 2.56–2.69
(m, 2H, CH2), 1.44 ppm (s, 9H, C(CH3)3) ;
13C NMR: (400 MHz, CDCl3)
for ()-9 : d=159.37, 157.04, 134.25, 133.13, 127.32, 112.03 110.33,
103.54, 81.22, 64.49, 53.24, 40.36, 28.89, 21.85 ppm; Anal. calcd. for
C17H21FN2O3 : C 63.74, H 6.61, N 8.74, found: C 63.70, H 6.71, N 8.68.
Enzymatic resolutions
Enzymatic resolution of ()-7
To ()-7 (0.5 g, 1.66 mmol) in toluene (30 mL), lipase CAL-B
(900 mg) and acetic anhydride (2 equiv, 310 mL) were added, and
the reaction mixture was shaken in an incubator shaker at 60 8C for
1.5 h. The reaction was stopped at 50% conversion (ee=98%) by
filtering off the enzyme, and the solvent was then evaporated off.
The products were separated by column chromatography on
silica [eluent: n-hexane:EtOAc (2:1)] , resulting in the unreacted
amino alcohol (R)-7 as light-yellow crystals [235 mg, yield: 47%,
[a]D
25= +107.5 (c=0.34 in EtOH), m.p.=136–137 8C, Rf=0.24] and
the product amino ester (S)-10 as white crystals [263 mg, yield:
46%, [a]D
25=¢102.2 (c=0.32 in EtOH), m.p.=124–125 8C, Rf=
0.76].
The 1H NMR (400 MHz, DMSO) spectroscopic data for (R)-7 were
similar to those for ()-7. 1H NMR (400 MHz, CDCl3) for (S)-10 : d=
7.98–8.15 (br s, 1H, NH), 7.52–7.54 (d, 1H, J=8.0 Hz, Ar–H), 7.37–
7.39 (d, 1H, J=7.6 Hz, Ar–H), 7.2–7.26 (t, J=7.5 Hz, 1H, Ar–H),
7.12–7.18 (t, J=7.2 Hz, 1H, Ar–H), 5.31–5.69 (m, 1H, CH), 4.29–4.47
(m, 1H, CH2 overlapping with m, 2H, CH2), 3.47–3.56 (m, 1H, CH2),
2.71–2.96 (m, 2H, CH2), 2.15 (s, 3H, CH3), 1.46 ppm (s, 9H, C(CH3)3) ;
13C NMR: (400 MHz, CDCl3) for (S)-10 : d=171.30, 136.70, 130.76,
127.06, 122.57, 120.00, 118.66, 111.47, 80.81, 65.16, 50.09, 39.90
28.87, 21.90, 21.37 ppm; Anal. calcd. for C19H24N2O4 : C 66.26, H
7.02, N 8.13, found: C 66.29, H 7.12, N 8.04.
Enzymatic resolution of ()-8
With the procedure described above, the reaction of ()-8
(200 mg, 0.6 mmol), in toluene (25 mL), CAL-B (750 mg) and acetic
anhydride (8 equiv, 466 mL) after 2.5 h resulted in (R)-8 as white
crystals [93 mg, yield: 47%, [a]D
25= +82 (c=0.23 in EtOH), m.p.=
196–198 8C, ee=98%, Rf=0.20, eluent: n-hexane:EtOAc (2:1)] and
(S)-11 as a yellow oil [98 mg, yield: 43%, [a]D
25=¢92.3 (c=0.61 in
EtOH), ee=98%, Rf=0.63, eluent: n-hexane:EtOAc (2:1)] .
The 1H NMR (400 MHz, DMSO) spectroscopic data for (R)-8 were
similar to those for ()-8. 1H NMR (400 MHz, DMSO) for (S)-11: d=
10.72–10.88 (d, 1H J=14.04 Hz, NH), 7.18–7.25 (d, 1H, J=8.4 Hz,
Ar–H), 6.89–6.94 (d, 1H, J=2.12 Hz, Ar–H), 6.69–6.75 (dd, 1H, J=
2.34 Hz, 8.84 Hz, Ar–H), 5.28–5.47 (m, 1H, CH), 4.10-4.50 (m, 2H,
CH2 overlapping with m, 2H, CH2), 3.75 (s, 3H, CH3), 2.55–2.73 (m,
2H, CH2), 1.95–2.10 (m, 3H, CH3), 1.44 ppm (s, 9H, C(CH3)3) ;
13C NMR: (400 MHz, CDCl3) for (S)-11: d=171.36, 154.56, 131.84,
127.45, 112.19, 100.96, 80.78, 65.07, 56.39, 50.17, 28.87, 21.93,
21.35 ppm; Anal. calcd. for C20H26N2O5 : C 64.15, H 7.00, N 7.48,
found: C 64.26, H 7.02, N 7.39.
Enzymatic resolution of ()-9
Similarly, the preparative-scale reaction of ()-9 (500 mg,
1.56 mmol) in toluene (50 mL), CAL-B (1500 mg) and acetic anhy-
dride (6 equiv, 885 mL) resulted after 2 h in (R)-9 as light-yellow
crystals [234 mg, isolated yield: 47%, [a]D
25= +97 (c=0.21 in
EtOH), m.p.=99–100 8C, ee=96%, Rf=0.12, eluent: n-hexane:E-
tOAc (3:1)] and (S)-12 as white crystals [255 mg, isolated yield:
45%, [a]D
25=¢131.8 (c=0.38 in EtOH), m.p.=143–145 8C, ee=
98%, Rf=0.49, eluent: n-hexane:EtOAc (3:1)] .
The 1H NMR (400 MHz, DMSO) spectroscopic data for (R)-9 were
similar to those for ()-9. 1H NMR (400 MHz, DMSO) for (S)-12 : d=
10.99–11.21 (d, 1H, J=16 Hz, NH), 7.27–7.35 (2d, J=4.6 Hz, 1H, Ar–
H), 7.15–7.21 (dd, 1H, J=2.4 Hz, 9.82 Hz, Ar–H), 6.87–6.96 (dt, J=
2.5 Hz, 9.4 Hz, 1H, Ar–H), 5.31–5.53 (d, 1H, J=27.4 Hz, CH), 4.10–
4.59 (m, 2H, CH2 overlapping with m, 2H, CH2), 2.55–2.70 (m, 2H,
CH2), 1.94–2.12 (m, 3H, CH3), 1.44 ppm (s, 9H, C(CH3)3) ;
13C NMR:
(400 MHz, CDCl3) for (S)-12 : d=171.31, 159.46, 157.12, 133.17,
132.64, 127.45, 111.98, 110.79, 103.73, 80.94, 65.07, 50.13, 28.85,
21.82, 21.35 ppm; Anal. calcd. for C19H23N2O4 : C 62.97, H 6.40, N
7.73, found: C 62.89, H 6.44, N 7.78.
Deacylation of (S)-10, (S)-11, and (S)-12
Enantiomeric (S)-10 (30 mg, 0.09 mmol), (S)-11 (40 mg, 0.11 mmol),
or (S)-12 (50 mg, 0.14 mmol) was dissolved in MeOH (10 mL).
K2CO3 (50 mg, 0.36 mmol) was added, and the reaction mixture
was shaken at 60 8C for 10 min. The following products were ob-
tained as white crystals: (S)-7 [24 mg, yield: 90%, [a]D
25=¢108.8
(c=0.33 in EtOH), m.p.=135–137 8C, ee=98%, Rf=0.48, eluent: n-
hexane:EtOAc (1:1)] , (S)-8 [31 mg, yield: 88%, [a]D
25=¢81 (c=0.12
in EtOH), m.p.=195–197 8C, ee=98%, Rf=0.47, eluent: n-hexane:
EtOAc (1:1)] , or (S)-9 [33 mg, yield: 75%, [a]D
25=¢105 (c=0.195 in
EtOH), m.p.=98–100 8C, ee=98%, Rf=0.20, eluent: n-hexane:
EtOAc (3:1)] .
Deprotection of (R)-7, (R)-8, (R)-9, (S)-10, (S)-11, and (S)-12
(R)-7 (50 mg, 0.16 mmol), (R)-8 (30 mg, 0.09 mmol), (R)-9 (30 mg,
0.09 mmol), (S)-10 (50 mg, 0.15 mmol), (S)-11 (40 mg, 0.1 mmol), or
(S)-12 (30 mg, 0.08 mmol) was suspended in water (5 mL) in
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a tube, and stirred at 100 8C for 1 h under maximum MW irradia-
tion of 150 W. The solvent was evaporated off, and the residue was
purified by column chromatography with toluene:MeOH (1:1) as
eluent. The following products were crystallized from n-hexane:
(R)-4 as yellow crystals [26 mg, yield: 79%, [a]D
25=¢37.8 (c=0.41
in EtOH), m.p.=145–147 8C, ee=98%, Rf=0.15], (S)-4 as yellow
crystals [15 mg, yield: 52%, [a]D
25= +36.1 (c=0.4 in EtOH), m.p.=
146–147 8C, ee=98%, Rf=0.16], (R)-5 as light-yellow crystals [8 mg,
yield: 38%, [a]D
25=¢22.0 (c=0.4 in EtOH), m.p.=167–168 8C, ee=
98%, Rf=0.18], (S)-5 as light-yellow crystals [9 mg, yield: 38%,
[a]D
25= +21.8 (c=0.45 in EtOH), m.p.=168-170 8C, ee=98%, Rf=
0.21], (R)-6 as light-yellow crystals [11 mg, yield: 52%, [a]D
25=¢29
(c=0.155 in EtOH), m.p.=96-98 8C, ee=96%, Rf=0.14], or (S)-6 as
light-yellow crystals [5 mg, yield: 28%, [a]D
25= +29 (c=0.25 in
EtOH), m.p.=99-101 8C, ee=98%, Rf=0.18].
Synthesis of racemic and enantiomeric 1-hydroxymethyl-2-
acetyl-1,2,3,4-tetrahydro-b-carboline [()-13 and (R)-13]
A mixture of ()-4 (30 mg, 0.13 mmol), 6 equiv acetic anhydride
(75 mL, 0.8 mmol) and NaOH (100 mg, 2.5 mmol) in CH2Cl2 (20 mL)
and water (20 mL) was stirred for 48 h at rt. The reaction mixture
was then extracted with CH2Cl2 (3Õ15 mL). The organic phase was
dried on anhydrous Na2SO4 and evaporated. The resulting dark-
yellow oil was purified by column chromatography with
CH2Cl2 :MeOH (30:1) as eluent. The product ()-13 (18 mg, yield:
49%, m.p.=191–192 8C, Rf=0.10) was obtained as white crystals
from EtOH and diisopropyl ether (1:9).
1H NMR (400 MHz, CDCl3) for ()-13 : d=8.58–8.71 (br s, 1H, NH),
7.44–7.49 (d, J=7.72 Hz, 1H, Ar–H), 7.31–7.35 (d, J=8.36 Hz, 1H,
Ar–H), 7.13–7.20 (dt, J=1 Hz, 7.02 Hz, 1H, Ar–H), 7.06–7.13 (t, J=
7.2 Hz, 1H, Ar–H), 5.74–5.82 (t, J=6.56 Hz, 1H, CH), 3.96–4.11 (m,
2H, CH2), 3.84–3.93 (m, 1H, CH2), 3.43–3.55 (m, 1H, CH2), 2.79–2.96
(m, 2H, CH2), 2.29 ppm (s, 3H, CH3).
With the above procedure, the reaction of (R)-4 (26 mg, 0.11 mmol)
resulted in the desired product (R)-13 as white crystals [22 mg,
yield: 70%, [a]D
25= +164 (c=0.2 in EtOH), m.p.=201–203 8C, ee=
98%]. The 1H NMR (400 MHz, CDCl3) spectroscopic data for (R)-13
were similar to those for ()-13.
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